AAAAAA

   
Results: 1-25 |
Results: 25
CONTINUATION OF INITIAL ANTIHYPERTENSIVE MEDICATION AFTER 1-YEAR OF THERAPY
Authors: BLOOM BS
Citation: Bs. Bloom, CONTINUATION OF INITIAL ANTIHYPERTENSIVE MEDICATION AFTER 1-YEAR OF THERAPY, Clinical therapeutics, 20(4), 1998, pp. 671-681
COST SAVINGS IN DUODENAL-ULCER THERAPY THROUGH HELICOBACTER-PYLORI ERADICATION COMPARED WITH CONVENTIONAL THERAPIES - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, MULTICENTER TRIAL
Authors: SONNENBERG A SCHWARTZ JS CUTLER AF VAKIL N BLOOM BS
Citation: A. Sonnenberg et al., COST SAVINGS IN DUODENAL-ULCER THERAPY THROUGH HELICOBACTER-PYLORI ERADICATION COMPARED WITH CONVENTIONAL THERAPIES - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, MULTICENTER TRIAL, Archives of internal medicine, 158(8), 1998, pp. 852-860
THE DIAGNOSTIC AND TREATMENT APPROACH TO 2 COMMON CONDITIONS BY THE PHYSICIAN MEMBERS OF A COMMUNITY-HEALTH MAINTENANCE ORGANIZATION
Authors: BLOOM BS SMITH WP WEITZ D LAMONT B
Citation: Bs. Bloom et al., THE DIAGNOSTIC AND TREATMENT APPROACH TO 2 COMMON CONDITIONS BY THE PHYSICIAN MEMBERS OF A COMMUNITY-HEALTH MAINTENANCE ORGANIZATION, American journal of managed care, 3(5), 1997, pp. 733-736
UNTITLED - REPLY
Authors: BLOOM BS
Citation: Bs. Bloom, UNTITLED - REPLY, American journal of managed care, 3(10), 1997, pp. 1616-1616
IMMEDIATE ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH PREVIOUSLY DOCUMENTED PEPTIC-ULCER DISEASE - CLINICAL AND ECONOMIC-EFFECTS
Authors: FENDRICK AM MCCORT JT CHERNEW ME HIRTH RA PATEL C BLOOM BS
Citation: Am. Fendrick et al., IMMEDIATE ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH PREVIOUSLY DOCUMENTED PEPTIC-ULCER DISEASE - CLINICAL AND ECONOMIC-EFFECTS, The American journal of gastroenterology, 92(11), 1997, pp. 2017-2024
TIMING AND TIMELINESS IN MEDICAL-CARE EVALUATION
Authors: BLOOM BS FENDRICK AM
Citation: Bs. Bloom et Am. Fendrick, TIMING AND TIMELINESS IN MEDICAL-CARE EVALUATION, PharmacoEconomics, 9(3), 1996, pp. 183-187
CLINICAL AND ECONOMIC-EFFECTS OF MUPIROCIN CALCIUM ON PREVENTING STAPHYLOCOCCUS-AUREUS INFECTION IN HEMODIALYSIS-PATIENTS - A DECISION-ANALYSIS
Authors: BLOOM BS FENDRICK AM CHERNEW ME PATEL P
Citation: Bs. Bloom et al., CLINICAL AND ECONOMIC-EFFECTS OF MUPIROCIN CALCIUM ON PREVENTING STAPHYLOCOCCUS-AUREUS INFECTION IN HEMODIALYSIS-PATIENTS - A DECISION-ANALYSIS, American journal of kidney diseases, 27(5), 1996, pp. 687-694
THE TENSION BETWEEN COST-CONTAINMENT AND THE UNDERUTILIZATION OF EFFECTIVE HEALTH-SERVICES
Authors: BLOOM BS FENDRICK AM
Citation: Bs. Bloom et Am. Fendrick, THE TENSION BETWEEN COST-CONTAINMENT AND THE UNDERUTILIZATION OF EFFECTIVE HEALTH-SERVICES, International journal of technology assessment in health care, 12(1), 1996, pp. 1-8
PREDICTING EFFECTS OF MINIMAL INVASIVE THERAPY
Authors: BLOOM BS FENDRICK AM MCLANE C
Citation: Bs. Bloom et al., PREDICTING EFFECTS OF MINIMAL INVASIVE THERAPY, Health policy, 35(2), 1996, pp. 179-187
IMMEDIATE ENDOSCOPY OR INITIAL HELICOBACTER-PYLORI SEROLOGICAL TESTING FOR SUSPECTED PEPTIC-ULCER DISEASE - ESTIMATING COST-EFFECTIVENESS USING DECISION-ANALYSIS
Authors: FENDRICK AM CHERNEW ME HIRTH RA BLOOM BS
Citation: Am. Fendrick et al., IMMEDIATE ENDOSCOPY OR INITIAL HELICOBACTER-PYLORI SEROLOGICAL TESTING FOR SUSPECTED PEPTIC-ULCER DISEASE - ESTIMATING COST-EFFECTIVENESS USING DECISION-ANALYSIS, The Yale journal of biology & medicine, 69(2), 1996, pp. 187-195
BACTERIAL VAGINOSIS AND PRETERM BIRTH
Authors: BLOOM BS LEE DW
Citation: Bs. Bloom et Dw. Lee, BACTERIAL VAGINOSIS AND PRETERM BIRTH, The New England journal of medicine, 334(20), 1996, pp. 1338-1338
EVALUATION OF INITIAL NONINVASIVE THERAPY IN PEDIATRIC-PATIENTS PRESENTING WITH SUSPECTED ULCER DISEASE
Authors: OLSON AD FENDRICK AM DEUTSCH D CHERNEW ME HIRTH RA PATEL C BLOOM BS
Citation: Ad. Olson et al., EVALUATION OF INITIAL NONINVASIVE THERAPY IN PEDIATRIC-PATIENTS PRESENTING WITH SUSPECTED ULCER DISEASE, Gastrointestinal endoscopy, 44(5), 1996, pp. 554-561
OMEPRAZOLE OR RANITIDINE PLUS METOCLOPRAMIDE FOR PATIENTS WITH SEVEREEROSIVE ESOPHAGITIS - A COST-EFFECTIVENESS ANALYSIS
Authors: BLOOM BS HILLMAN AL LAMONT B LISS C SCHWARTZ JS STEVER GJ
Citation: Bs. Bloom et al., OMEPRAZOLE OR RANITIDINE PLUS METOCLOPRAMIDE FOR PATIENTS WITH SEVEREEROSIVE ESOPHAGITIS - A COST-EFFECTIVENESS ANALYSIS, PharmacoEconomics, 8(4), 1995, pp. 343-349
COST AND QUALITY EFFECTS OF TREATING EROSIVE ESOPHAGITIS - A REEVALUATION
Authors: BLOOM BS
Citation: Bs. Bloom, COST AND QUALITY EFFECTS OF TREATING EROSIVE ESOPHAGITIS - A REEVALUATION, PharmacoEconomics, 8(2), 1995, pp. 139-146
CRITICAL ISSUES SURROUNDING HEPATITIS-B VACCINATION FOR ADOLESCENTS -A ROUND-TABLE
Authors: BROOKMAN RR KOFF RS SCHAFFNER W MARGOLIS HS COLLINS M BLOOM BS COUPEY SM
Citation: Rr. Brookman et al., CRITICAL ISSUES SURROUNDING HEPATITIS-B VACCINATION FOR ADOLESCENTS -A ROUND-TABLE, Journal of adolescent health, 17(4), 1995, pp. 208-233
DIFFUSION OF LAPAROSCOPIC CHOLECYSTECTOMY AMONG GENERAL SURGEONS IN THE UNITED-STATES
Authors: ESCARCE JJ BLOOM BS HILLMAN AL SHEA JA SCHWARTZ JS
Citation: Jj. Escarce et al., DIFFUSION OF LAPAROSCOPIC CHOLECYSTECTOMY AMONG GENERAL SURGEONS IN THE UNITED-STATES, Medical care, 33(3), 1995, pp. 256-271
CLINICAL AND ECONOMIC-ANALYSIS OF IMMEDIATE ENDOSCOPY, SEROLOGICAL SCREENING FOR HELICOBACTER-PYLORI AND EMPIRIC TREATMENT OF HELICOBACTER-PYLORI FOR PEDIATRIC-PATIENTS WITH DYSPEPSIA
Authors: OLSON AD DEUTSCH D LOUISJACQUES O FENDRICK AM CHERNEW ME HIRTH RA BLOOM BS
Citation: Ad. Olson et al., CLINICAL AND ECONOMIC-ANALYSIS OF IMMEDIATE ENDOSCOPY, SEROLOGICAL SCREENING FOR HELICOBACTER-PYLORI AND EMPIRIC TREATMENT OF HELICOBACTER-PYLORI FOR PEDIATRIC-PATIENTS WITH DYSPEPSIA, Gastrointestinal endoscopy, 41(4), 1995, pp. 341-341
ALTERNATIVE TREATMENT STRATEGIES FOR PATIENTS WITH DYSPEPSIA IN THE HELICOBACTER-PYLORI ERA
Authors: FENDRICK AM CHERNEW ME HIRTH RA BLOOM BS
Citation: Am. Fendrick et al., ALTERNATIVE TREATMENT STRATEGIES FOR PATIENTS WITH DYSPEPSIA IN THE HELICOBACTER-PYLORI ERA, Gastroenterology, 108(4), 1995, pp. 13-13
ALTERNATIVE MANAGEMENT STRATEGIES FOR PATIENTS WITH SUSPECTED PEPTIC-ULCER DISEASE
Authors: FENDRICK AM CHERNEW ME HIRTH RA BLOOM BS
Citation: Am. Fendrick et al., ALTERNATIVE MANAGEMENT STRATEGIES FOR PATIENTS WITH SUSPECTED PEPTIC-ULCER DISEASE, Annals of internal medicine, 123(4), 1995, pp. 260-268
COST-EFFECTIVENESS OF HEPATITIS-B IMMUNIZATION STRATEGIES
Authors: HILLMAN AL BLASCO I BLOOM BS SCHWARTZ JS
Citation: Al. Hillman et al., COST-EFFECTIVENESS OF HEPATITIS-B IMMUNIZATION STRATEGIES, PharmacoEconomics, 5(2), 1994, pp. 85-87
STRATEGIES IN STAPHYLOCOCCUS-AUREUS INFECTION IN DIALYSIS PATIENTS
Authors: BLOOM BS
Citation: Bs. Bloom, STRATEGIES IN STAPHYLOCOCCUS-AUREUS INFECTION IN DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 434-434
THE US VIEWPOINT
Authors: BLOOM BS
Citation: Bs. Bloom, THE US VIEWPOINT, Cardiology, 85, 1994, pp. 96-101
IMPROVED HEALTH BENEFITS OF INCREASED USE OF THROMBOLYTIC THERAPY
Authors: FENDRICK AM RIDKER PM BLOOM BS
Citation: Am. Fendrick et al., IMPROVED HEALTH BENEFITS OF INCREASED USE OF THROMBOLYTIC THERAPY, Archives of internal medicine, 154(14), 1994, pp. 1605-1609
TIME TRENDS IN PEPTIC-ULCER DISEASE AND IN GASTRITIS AND DUODENITIS -MORTALITY, UTILIZATION, AND DISABILITY IN THE UNITED-STATES
Authors: BLOOM BS KROCH E
Citation: Bs. Bloom et E. Kroch, TIME TRENDS IN PEPTIC-ULCER DISEASE AND IN GASTRITIS AND DUODENITIS -MORTALITY, UTILIZATION, AND DISABILITY IN THE UNITED-STATES, Journal of clinical gastroenterology, 17(4), 1993, pp. 333-342
COST AND EFFECTIVENESS OF HEPATITIS-B IMMUNIZATION - RESPONSE
Authors: BLOOM BS HILLMAN AL FENDRICK AM SCHWARTZ JS
Citation: Bs. Bloom et al., COST AND EFFECTIVENESS OF HEPATITIS-B IMMUNIZATION - RESPONSE, Annals of internal medicine, 119(6), 1993, pp. 537-537
Risultati: 1-25 |